1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:69487 6480464 CREB1 mutant form inhibits the reaction [2 more ... CTD PMID:19238344 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:69487 6480464 2 more ... CTD PMID:19238344 1,2-dimethylhydrazine increases expression ISO RGD:69488 6480464 1, 2-Dimethylhydrazine results in increased expression of WISP1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CCN4 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CCN4 mRNA CTD PMID:17351261 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:69488 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69488 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCN4 mRNA CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69488 6480464 Tetrachlorodibenzodioxin affects the expression of CCN4 mRNA CTD PMID:21570461 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:69488 6480464 NOS2 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCN4 mRNA] CTD PMID:19238344 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of CCN4 mRNA CTD PMID:23537331 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:69488 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CCN4 mRNA CTD PMID:19238344 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:69488 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CCN4 mRNA CTD PMID:20188158 3-methylcholanthrene decreases expression ISO RGD:69488 6480464 Methylcholanthrene results in decreased expression of CCN4 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane decreases expression ISO RGD:69488 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CCN4 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:69487 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of CCN4 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol increases expression ISO RGD:69488 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CCN4 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69488 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of CCN4 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:69488 6480464 Decitabine results in increased expression of CCN4 mRNA CTD PMID:27915011 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CCN4 mRNA CTD PMID:25825206 actinomycin D multiple interactions ISO RGD:69487 6480464 Dactinomycin inhibits the reaction [2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA] CTD PMID:19238344 all-trans-retinoic acid multiple interactions ISO RGD:69488 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of CCN4 mRNA more ... CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CCN4 mRNA CTD PMID:16483693 arsane affects expression ISO RGD:69487 6480464 Arsenic affects the expression of CCN4 protein CTD PMID:24675094 arsenic atom affects expression ISO RGD:69487 6480464 Arsenic affects the expression of CCN4 protein CTD PMID:24675094 arsenous acid decreases expression ISO RGD:69487 6480464 Arsenic Trioxide results in decreased expression of CCN4 mRNA, Arsenic Trioxide results in decreased expression of WISP1 mRNA CTD PMID:20458559 , PMID:26705709 benzo[a]pyrene decreases expression ISO RGD:69488 6480464 Benzo(a)pyrene results in decreased expression of CCN4 mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:69487 6480464 Benzo(a)pyrene affects the methylation of WISP1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:69487 6480464 Benzo(a)pyrene results in increased methylation of WISP1 5' UTR, Benzo(a)pyrene results in increased methylation of WISP1 exon CTD PMID:27901495 benzo[a]pyrene affects expression ISO RGD:69488 6480464 Benzo(a)pyrene affects the expression of CCN4 mRNA CTD PMID:22342234 benzo[b]fluoranthene increases expression ISO RGD:69488 6480464 benzo(b)fluoranthene results in increased expression of CCN4 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69487 6480464 Diethylhexyl Phthalate results in increased expression of CCN4 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CCN4 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:69487 6480464 bisphenol A results in decreased methylation of CCN4 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:69488 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of CCN4 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:69488 6480464 bisphenol A results in increased expression of CCN4 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:69488 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CCN4 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:69488 6480464 bisphenol F results in increased expression of CCN4 mRNA CTD PMID:30951980 cadmium dichloride increases expression ISO RGD:69487 6480464 Cadmium Chloride results in increased expression of CCN4 mRNA CTD PMID:21457566 calcitriol decreases expression ISO RGD:69487 6480464 Calcitriol results in decreased expression of CCN4 mRNA CTD PMID:26485663 cannabidiol multiple interactions ISO RGD:69487 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of WISP1 mRNA] CTD PMID:31250491 carbon nanotube increases expression ISO RGD:69488 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:69487 6480464 CCN4 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chloroprene decreases expression ISO RGD:69488 6480464 Chloroprene results in decreased expression of CCN4 mRNA CTD PMID:23125180 cisplatin increases expression ISO RGD:69488 6480464 Cisplatin results in increased expression of CCN4 mRNA CTD PMID:21151649 copper atom multiple interactions ISO RGD:69488 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCN4 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:69488 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCN4 mRNA CTD PMID:15467011 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CCN4 mRNA CTD PMID:26577399 , PMID:27523638 cycloheximide multiple interactions ISO RGD:69487 6480464 Cycloheximide inhibits the reaction [2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA] CTD PMID:19238344 cyclosporin A decreases expression ISO RGD:69487 6480464 Cyclosporine results in decreased expression of CCN4 mRNA CTD PMID:33631201 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of CCN4 mRNA CTD PMID:23640034 dexamethasone decreases expression ISO RGD:69488 6480464 Dexamethasone results in decreased expression of CCN4 mRNA CTD PMID:22733784 diarsenic trioxide decreases expression ISO RGD:69487 6480464 Arsenic Trioxide results in decreased expression of CCN4 mRNA, Arsenic Trioxide results in decreased expression of WISP1 mRNA CTD PMID:20458559 , PMID:26705709 dibenz[a,h]anthracene increases expression ISO RGD:69488 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:69488 6480464 Dibutyl Phthalate results in increased expression of CCN4 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:69488 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN4 mRNA CTD PMID:30529165 doxorubicin decreases expression ISO RGD:69487 6480464 Doxorubicin results in decreased expression of CCN4 mRNA CTD PMID:29803840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CCN4 mRNA CTD PMID:30307764 folic acid affects expression ISO RGD:69487 6480464 Folic Acid affects the expression of CCN4 mRNA CTD PMID:17320366 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of WISP1 mRNA CTD PMID:33387578 graphite affects expression EXP 6480464 Graphite affects the expression of CCN4 mRNA CTD PMID:29933104 homocysteine decreases expression ISO RGD:69487 6480464 Homocysteine results in decreased expression of CCN4 mRNA CTD PMID:17320366 indometacin decreases expression ISO RGD:69487 6480464 Indomethacin results in decreased expression of CCN4 mRNA, Indomethacin results in decreased expression of CCN4 protein CTD PMID:17054584 methotrexate decreases expression ISO RGD:69487 6480464 Methotrexate results in decreased expression of CCN4 mRNA CTD PMID:17320366 methylmercury chloride decreases expression ISO RGD:69487 6480464 methylmercuric chloride results in decreased expression of CCN4 mRNA CTD PMID:23179753 N-nitrosodiethylamine multiple interactions ISO RGD:69488 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCN4 mRNA CTD PMID:24535843 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of CCN4 mRNA CTD PMID:33484710 nitroprusside increases expression ISO RGD:69487 6480464 Nitroprusside results in increased expression of CCN4 mRNA, Nitroprusside results in increased expression of CCN4 protein CTD PMID:19238344 ochratoxin A increases expression ISO RGD:69487 6480464 ochratoxin A analog results in increased expression of CCN4 mRNA, ochratoxin A results in increased expression of CCN4 mRNA CTD PMID:27422291 oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of CCN4 mRNA CTD PMID:25729387 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of WISP1 mRNA CTD PMID:33387578 pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of CCN4 mRNA CTD PMID:25710175 perfluorohexanesulfonic acid increases expression ISO RGD:69487 6480464 perfluorohexanesulfonic acid results in increased expression of WISP1 mRNA CTD PMID:25812627 perfluorononanoic acid increases expression ISO RGD:69487 6480464 perfluoro-n-nonanoic acid results in increased expression of WISP1 mRNA CTD PMID:25812627 phenobarbital multiple interactions ISO RGD:69488 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCN4 mRNA, NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of CCN4 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:69488 6480464 Phenobarbital results in increased expression of CCN4 mRNA CTD PMID:19270015 more ... pirinixic acid multiple interactions ISO RGD:69488 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCN4 mRNA CTD PMID:19710929 propiconazole increases expression ISO RGD:69488 6480464 propiconazole results in increased expression of CCN4 mRNA CTD PMID:21278054 silver atom decreases expression ISO RGD:69488 6480464 Silver results in decreased expression of CCN4 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:69488 6480464 Silver results in decreased expression of CCN4 mRNA CTD PMID:27131904 temozolomide affects response to substance ISO RGD:69487 6480464 CCN4 mRNA affects the susceptibility to Temozolomide CTD PMID:16365179 tetrachloromethane affects expression ISO RGD:69488 6480464 Carbon Tetrachloride affects the expression of CCN4 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:69488 6480464 Carbon Tetrachloride results in increased expression of CCN4 mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide increases expression ISO RGD:69488 6480464 titanium dioxide results in increased expression of CCN4 mRNA CTD PMID:23557971 , PMID:27760801 topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of CCN4 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of WISP1 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:69488 6480464 trimellitic anhydride results in increased expression of CCN4 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:69487 6480464 Troglitazone results in decreased expression of CCN4 mRNA CTD PMID:28934090 valproic acid increases methylation ISO RGD:69487 6480464 Valproic Acid results in increased methylation of CCN4 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:69488 6480464 Vancomycin results in decreased expression of CCN4 mRNA CTD PMID:18930951